Lung cancer vaccine tested on patient for the first time

It is hoped the jab will bolster a person’s immune response to cancer while leaving healthy cells untouched, unlike chemotherapy

The trial will take place across 34 research sites in seven countries, with six located in England and Wales (Aaron Chown/PA)

A new vaccine that primes the immune system to recognise and fight lung cancer is being tested for the first time on patients.

Researchers leading the trial said the treatment could improve survival rates among people with the disease, with hopes that it could eventually become the standard of care worldwide.